Till Bärnighausen, Associate Professor of Global Health
Global Health and Population
Harvard Center for Population and Development Studies
Dates of Research:
August 1, 2012 — December 31, 2013
Since South Africa began its national rollout of antiretroviral therapy (ART) for HIV in 2004, adult life expectancy has increased dramatically. However, in the general population in-depth knowledge about ART and its impact on survival is incomplete. We will implement a randomized life-expectancy information intervention to assess whether information on ART affects subjective life expectancy, and in turn, whether subjective life expectancy impacts other economic preferences and behaviors.